Ganding, Baby Boy 1 -.

HRN: 26-57-51  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/22/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/22/2025
01/29/2025
IV
30mg
Q24H
PSNB
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: